Markets

Tuesday 1/2 Insider Buying Report: RETA, CSWC

Shutterstock photo
Shutterstock photo

Shutterstock photo

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Friday, Reata Pharmaceuticals ( RETA ), R. Kent McGaughy Jr., made a $484,016 buy of RETA, purchasing 17,000 shares at a cost of $28.47 a piece. Reata Pharmaceuticals Inc is trading off about 0.3% on the day Tuesday. Before this latest buy, McGaughy Jr. bought RETA at 2 other times during the past twelve months, for a total cost of $5.66M at an average of $24.93 per share.

And at Capital Southwest ( CSWC ), there was insider buying on Thursday, by Director David R. Brooks who bought 2,000 shares for a cost of $16.66 each, for a total investment of $33,326. Before this latest buy, Brooks made one other buy in the past twelve months, purchasing $166,217 shares at a cost of $15.98 a piece. Capital Southwest is trading up about 1.9% on the day Tuesday.

VIDEO: Tuesday 1/2 Insider Buying Report: RETA, CSWC

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CSWC RETA

Latest Markets Videos